医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

DxPx partners with MyBioGate for China

2019年08月28日 PM08:55
このエントリーをはてなブックマークに追加


 

DUESSELDORF, Germany

DxPx Conference has another strong partner: MyBioGate Inc.. “Our cooperation with MyBioGate gives us access to the Chinese markets and further increases our Conference’s impetus and reach”, says Dr. Mirko Stange, initiator of DxPx. DxPx Conference, which will be launched in Duesseldorf (at the Maritim Airport Hotel), Germany, on November 18, 2019. It is the first international partnering conference focusing specifically on the diagnostics industry. The event, which targets established companies, startups, and investors, will always take place on the MEDICA opening day to also attract participants from Asia and the U.S. MEDICA, itself also a DxPx Conference partner, considers the conference an asset for the Duesseldorf site and an added benefit for the fair visitor’s businesses. To date, participants from over 15 countries have registered for DxPx Conference.

“Our partner MyBioGate will enable contacts with Chinese investors and feature a special highlight for young enterprises: the “Best Dx Start up Awards 2019.” Together with MyBioGate we will select six start ups who will either fly to China for a one-week investor roadshow, or to San Francisco, USA, during the J.P Morgan Conference”, says Dr. Mirko Stange. “For us at MyBioGate the DxPx is a unique opportunity to get in touch with new startups and we are looking forward to invite the most promising company for a fully paid investor roadshow to China”, says Xin Xin Li, Vice President of Strategic Partnerships.

Interested young enterprises should apply now for a chance to present their ideas and products live on stage to an international audience. Application is free of charge; to enter applicants must submit a short business plan. Sponsors and selected industry experts will act as the Award’s jury. Please upload your business plan at: www.dxpx-conference.com.

DxPx Conference sponsors and partners, in addition to MyBioGate and MEDICA, are Roche Diagnostics, Sonic Healthcare’s Bioscientia, Pillar Biosciences, Medicover, and Hightech Gründerfund, Europe’s leading startup investor, McDermott Will & Emery as well as Aescuvest. Negotiations with additional renowned international sponsors are ongoing.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190828005392/en/

CONTACT

Dr. Mirko Stange

CEO SilverSky LifeSciences GmbH

info@dxpx-conference.com

Press contact:

Wordstatt GmbH

Dagmar Metzger

Tel: +49-89-3577579-0

Email: info@wordstatt.de

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 拓臻生物公布其非酒精性脂肪性肝炎(NASH)候选药物-具有肝脏选择性的法尼醇X受体(FXR)激动剂TERN-101-临床Ⅰ期试验安全性和药效学研究结果
  • Terns Pharmaceuticals Announces Safety and Pharmacodynamic Results of a Phase 1 Clinical Trial of TERN-101, a Liver-Selective FXR Agonist in Development for the Treatment of NASH
  • AVITA Medical Half-Year Financial Report for Fiscal 2020
  • 西联汇款启动抗击新型冠状病毒的全球援助项目
  • Jinsan Beverage of Korea Introduces Its 5 Healthy Smoothies for Spring